CEO Larry Wood was paid $16,783,853 in fiscal year 2025, the 99th percentile of its disclosed peer group (SEC filing 0001588978-26-000017 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$16,783,853 Larry Wood total, FY2025 | 99th CEO pay percentile vs peers | 132:1 CEO-to-median pay ratio | 73.11% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
PRCT's next annual pay disclosure, estimated April 19, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Larry Wood | $304,830 | $1,700,000 | $7,217,251 | $7,226,599 | $243,864 | $0 | $91,309 | $16,783,853 |
| President & Chief Executive Officer | ||||||||
| Reza Zadno | 471,306 | 0 | 3,790,409 | 1,289,314 | 472,000 | 0 | 743,247 | 6,766,276 |
| Former President & Chief Executive Officer | ||||||||
| Kevin Waters | 502,250 | 0 | 1,480,761 | 503,594 | 256,148 | 0 | 7,500 | 2,750,253 |
| EVP, Chief Financial Officer | ||||||||
| Alaleh Nouri | 471,500 | 0 | 1,177,882 | 400,586 | 220,426 | 0 | 7,500 | 2,277,894 |
| EVP, Chief Legal Officer & Corporate Secretary | ||||||||
| Hisham Shiblaq | 335,958 | 0 | 1,009,596 | 343,372 | 0 | 0 | 275,814 | 1,964,740 |
| Former EVP, Chief Commercial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Larry Wood | $16,783,853 | — | — | — |
| Reza Zadno | 6,766,276 | 6,521,876 | 6,088,813 | ↑ +244,400 |
| Kevin Waters | 2,750,253 | 2,187,988 | 2,665,306 | ↑ +562,265 |
| Alaleh Nouri | 2,277,894 | 2,653,751 | 2,193,961 | ↓ −375,857 |
| Hisham Shiblaq | 1,964,740 | 3,587,208 | 2,631,135 | ↓ −1,622,468 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read PROCEPT BioRobotics's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper PRCT reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses PRCT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named PRCT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Amy Dodrill | Independent Director | $263,520 |
| Antal Desai | Independent Director | $258,520 |
| Daniel Puckett | Independent Director | — |
| Elisabeth Little | Independent Director | $266,020 |
| Frederic Moll, M.D | Independent Director | $246,020 |
| Mary Garrett | Independent Director | $256,020 |
| Taylor Harris | Independent Director | $266,020 |
| Thomas M. Prescott | Chair of the Board | $297,852 |
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Barry L. Templin | EVP, Chief Technology Officer | 2026-06-08 | D | 358 | $28 | $10,195 | Common | Form 4 ↗ |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | 2026-06-08 | D | 285 | 28 | 8,117 | Common | Form 4 ↗ |
| Kevin Waters | EVP, CFO | 2026-06-08 | D | 357 | 28 | 10,167 | Common | Form 4 ↗ |
| Daniel Puckett | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Frederic H. Moll | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Antal Desai | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Mary Garrett | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Daniel Puckett | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thomas M. Prescott | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Thomas M. Prescott | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Frederic H. Moll | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elisabeth Little | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Elisabeth Little | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Taylor Harris | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Taylor Harris | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Mary Garrett | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Amy Dodrill | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Amy Dodrill | Director | 2026-06-09 | A | 3,315 | 0 | 0 | Common | Form 4 ↗ |
| Antal Desai | Director | 2026-06-09 | A | 5,853 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Larry L. Wood | Director | 2026-08-07 | A | 23,900 | 21 | 498,315 | Common | Form 4 ↗ |
| Barry L. Templin | EVP, Chief Technology Officer | 2026-08-13 | A | 26,246 | 0 | 0 | Common | Form 4 ↗ |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | 2026-08-13 | A | 31,773 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | 2026-08-13 | A | 22,965 | 0 | 0 | Common | Form 4 ↗ |
| Pooja Sharma | Chief Strat/Marketing Officer | 2026-08-13 | A | 32,681 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Pooja Sharma | Chief Strat/Marketing Officer | 2026-08-13 | A | 23,622 | 0 | 0 | Common | Form 4 ↗ |
| Kevin Waters | EVP, CFO | 2026-08-13 | A | 40,851 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kevin Waters | EVP, CFO | 2026-08-13 | A | 29,527 | 0 | 0 | Common | Form 4 ↗ |
| Barry L. Templin | EVP, Chief Technology Officer | 2026-08-13 | A | 36,312 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Barry L. Templin | EVP, Chief Technology Officer | 2026-09-09 | D | 373 | 21 | 7,815 | Common | Form 4 ↗ |
| Kevin Waters | EVP, CFO | 2026-09-09 | D | 373 | 21 | 7,815 | Common | Form 4 ↗ |
| Alaleh Nouri | EVP, CLO, CORP. SEC. | 2026-09-09 | D | 297 | 21 | 6,223 | Common | Form 4 ↗ |
| Michael Mack | Director | 2026-10-02 | A | 12,191 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Michael Mack | Director | 2026-10-02 | A | 7,727 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Alaleh Nouri | OPTION | 2025-03-03 | — | — | 11,445 | — | $400,586 |
| Alaleh Nouri | PSU | 2025-03-03 | 6,479 | 11,338 | — | 12,958 | 1,177,882 |
| Kevin Waters | PSU | 2025-03-03 | 8,145 | 14,254 | — | 16,290 | 1,480,761 |
| Hisham Shiblaq | PSU | 2025-03-03 | 5,553 | 9,718 | — | 11,107 | 1,009,596 |
| Larry Wood | RSU | 2025-09-02 | — | — | 182,392 | — | 7,217,251 |
| Reza Zadno | PSU | 2025-03-03 | 20,849 | 36,486 | — | 41,699 | 3,790,409 |
| Larry Wood | OPTION | 2025-09-02 | — | — | 319,618 | — | 7,226,599 |
| Reza Zadno | OPTION | 2025-03-03 | — | — | 36,831 | — | 1,289,314 |
| Hisham Shiblaq | OPTION | 2025-03-03 | — | — | 9,810 | — | 343,372 |
| Kevin Waters | OPTION | 2025-03-03 | — | — | 14,388 | — | 503,594 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Alaleh Nouri | $0 | $1,177,882 | $400,586 | 74.6% |
| Kevin Waters | 0 | 1,480,761 | 503,594 | 74.6% |
| Hisham Shiblaq | 0 | 1,009,596 | 343,372 | 74.6% |
| Larry Wood | 7,217,251 | 0 | 7,226,599 | 0.0% |
| Reza Zadno | 0 | 3,790,409 | 1,289,314 | 74.6% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Reza Zadno | Option | 4,974 | 34.99 | — |
| Kevin Waters | RSU | 16,290 | — | 512,483 |
| Kevin Waters | Option | 6,505 | 47.17 | — |
| Kevin Waters | RSU | 13,158 | — | 413,951 |
| Reza Zadno | RSU | 9,828 | — | 309,189 |
| Reza Zadno | RSU | 32,895 | — | 1,034,877 |
| Larry Wood | RSU | 182,392 | — | 5,738,052 |
| Reza Zadno | RSU | 36,432 | — | 1,146,151 |
| Kevin Waters | RSU | 6,637 | — | 208,800 |
| Kevin Waters | RSU | 2,036 | — | 64,053 |
| Larry Wood | Option | 734 | 51.08 | — |
| Reza Zadno | RSU | 5,212 | — | 163,970 |
| Kevin Waters | RSU | 2,697 | — | 84,848 |
| Kevin Waters | RSU | 9,957 | — | 313,247 |
| Reza Zadno | RSU | 24,287 | — | 764,069 |
| Larry Wood | Option | 319,618 | 39.57 | — |
| Reza Zadno | Option | 37,292 | 37.02 | — |
| Reza Zadno | Option | 23,800 | 47.17 | — |
| Kevin Waters | RSU | 1,979 | — | 62,259 |
| Kevin Waters | Option | 1,002 | 34.99 | — |
| Kevin Waters | Option | 14,917 | 37.02 | — |
Our executive compensation program is designed to attract and retain our NEOs, align the interests of our NEOs with the interests of our stockholders, and incentivize and reward performance that contributes to our short-term and long-term success. Generally, this is accomplished by tying a substantial portion of our NEOs total compensation to the achievement of meaningful pre-set, objective financial or operating goals, such as in our annual incentive program, or to our stock price, via our long-term incentive program, making it variable and thus putting it at risk.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Alpine |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-09 | 26,984,867 | 9,924,704 | 45,735 | 73.11% | Passed |
| 2025 | 2025-06-10 | 40,260,405 | 1,906,382 | 30,232 | 95.48% | Passed |
| 2024 | 2024-06-04 | 37,459,317 | 1,254,400 | 115,480 | 96.76% | Passed |
| 2022 | 2022-06-07 | — | — | — | — | — |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-09 | 73.11%a |
| 2025 | 2025-06-10 | 95.48%b |
| 2024 | 2024-06-04 | 96.76%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “Abstentions and broker-non-votes will not be considered votes cast on Proposal No. 3;”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 132 : 1 |
|---|---|
| CEO total compensation | $23,550,129 |
| Median employee compensation | $178,612 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Thomas M. PrescottIndependent · Board Chair · Audit | $100,376 | $98,786 | $98,690 | — | $0 | $297,852 |
| Taylor HarrisIndependent · Audit (Chair) | 68,544 | 98,786 | 98,690 | — | 0 | 266,020 |
| Elisabeth LittleIndependent · Compensation (Chair) · Nominating/Governance | 68,544 | 98,786 | 98,690 | — | 0 | 266,020 |
| Amy DodrillIndependent · Audit · Compensation | 66,044 | 98,786 | 98,690 | — | 0 | 263,520 |
| Antal DesaiIndependent · Compensation · Nominating/Governance | 61,044 | 98,786 | 98,690 | — | 0 | 258,520 |
| Mary GarrettIndependent · Nominating/Governance (Chair) | 58,544 | 98,786 | 98,690 | — | 0 | 256,020 |
| Frederic Moll, M.DIndependent | 48,544 | 98,786 | 98,690 | — | 0 | 246,020 |
| Larry L. WoodEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Daniel PuckettIndependent · Audit · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | $197,476 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 50,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $471,640 |
| Equity awards (grant-date value) | $691,502 |
| All other compensation | $0 |
| Total cost of the board | $1,163,142 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies PROCEPT BioRobotics names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including PROCEPT BioRobotics.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | PROCEPT BioRobotics | 2025 | Larry Wood | $304,830 | $7,217,251 | $7,226,599 | $243,864 | $16,783,853 |
| 2 | Silk Road Medical | 2023 | Chas McKhann | 105,871 | 13,123,059 | 0 | 93,275 | 13,423,834 |
| 3 | Nevro | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 4 | Revance Therapeutics | 2023 | Mark Foley | 720,000 | 8,810,731 | 0 | 522,720 | 10,068,915 |
| 5 | Inspire Medical Systems | 2025 | Timothy Herbert | 750,572 | 5,999,655 | 0 | 961,557 | 7,711,784 |
| 6 | Certara | 2025 | William Feehery | 795,675 | 4,927,502 | 0 | 747,935 | 6,491,387 |
| 7 | RxSight | 2025 | Ron Kurtz | 630,625 | 0 | 3,816,530 | 202,935 | 4,650,661 |
| 8 | OrthoPediatrics | 2025 | David Bailey | 550,000 | 2,445,200 | 0 | 322,281 | 3,331,481 |
| 9 | Paragon 28 | 2023 | Albert DaCosta | 700,769 | 1,832,495 | 0 | 667,400 | 3,232,420 |
| 10 | Penumbra | 2025 | Adam Elsesser | 850,000 | 0 | 0 | 0 | 851,621 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| PROCEPT BioRobotics | 80% | RSU 50 · PSU 25 · Options 25 | Yes — Relative TSR | Alpine |
| Certara | 94% | PSU 60 · RSU 40 | Yes — annualized total stockholder return (ATSR) | Meridian Compensation Partners |
| Inspire Medical Systems | 111.4% | PSU 50 · RSU 50 | No | Aon |
| Nevro | 53.7% | not disclosed | No | Aon |
| OrthoPediatrics | 78.2% | RSU 100 | not disclosed | NFP Compensation Consulting |
| Paragon 28 | 94% | RSU 100 | not disclosed | Compensia, Inc. |
| Penumbra | not disclosed | not disclosed | No | Compensia |
| Revance Therapeutics | 96.8% | PSU 100 | No | FW Cook |
| RxSight | 32.18% | Option 100 | not disclosed | Aon |
| Silk Road Medical | not disclosed | PSU 50 · RSU 50 | Yes — Total Stockholder Return (TSR) relative to peer group | Compensia, Inc. |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Larry Wood | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Summary Compensation Table”. As printed: 16,783,853. Filing ↗machine: r2 · c48 · span 520911–520921 |
| 2 | Section 01, Reza Zadno | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Summary Compensation Table”. As printed: 6,766,276. Filing ↗machine: r3 · c48 · span 523134–523143 |
| 3 | Section 01, Kevin Waters | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Summary Compensation Table”. As printed: 2,750,253. Filing ↗machine: r6 · c48 · span 529624–529633 |
| 4 | Section 01, Alaleh Nouri | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Summary Compensation Table”. As printed: 2,277,894. Filing ↗machine: r12 · c48 · span 543103–543112 |
| 5 | Section 01, Hisham Shiblaq | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Summary Compensation Table”. As printed: 1,964,740. Filing ↗machine: r9 · c48 · span 536599–536608 |
| 6 | Section 03, Alaleh Nouri OPTION | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r19 · c17 · span 618290–618296 |
| 7 | Section 03, Alaleh Nouri PSU | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r18 · c13 · span 614191–614197 |
| 8 | Section 03, Kevin Waters PSU | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r12 · c13 · span 594673–594679 |
| 9 | Section 03, Hisham Shiblaq PSU | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r15 · c13 · span 604334–604339 |
| 10 | Section 03, Larry Wood RSU | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r6 · c15 · span 575717–575724 |
| 11 | Section 03, Reza Zadno PSU | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t26 · r3 · c7 · span 522154–522163 |
| 12 | Section 03, Larry Wood OPTION | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r7 · c17 · span 579383–579390 |
| 13 | Section 03, Reza Zadno OPTION | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t26 · r3 · c9 · span 522400–522409 |
| 14 | Section 03, Hisham Shiblaq OPTION | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r16 · c17 · span 607807–607812 |
| 15 | Section 03, Kevin Waters OPTION | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Grants of Plan-Based Awards” · grants of plan-based awards table. Filing ↗machine: t27 · r13 · c17 · span 598772–598778 |
| 16 | Section 07, pay ratio | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “CEO Pay Ratio”. As printed: 132 : 1. Filing ↗machine: span 815315–815318 |
| 17 | Section 08, Thomas M. Prescott | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 297,852. Filing ↗machine: t12 · r9 · c10 · span 253186–253486 |
| 18 | Section 08, Taylor Harris | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 266,020. Filing ↗machine: t12 · r6 · c10 · span 247773–248073 |
| 19 | Section 08, Elisabeth Little | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 266,020. Filing ↗machine: t12 · r8 · c10 · span 251377–251677 |
| 20 | Section 08, Amy Dodrill | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 263,520. Filing ↗machine: t12 · r4 · c10 · span 244190–244490 |
| 21 | Section 08, Antal Desai | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 258,520. Filing ↗machine: t12 · r3 · c10 · span 242400–242700 |
| 22 | Section 08, Mary Garrett | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 256,020. Filing ↗machine: t12 · r5 · c10 · span 245981–246281 |
| 23 | Section 08, Frederic Moll, M.D | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 246,020. Filing ↗machine: t12 · r7 · c10 · span 249571–249871 |
| 24 | Section 08, Larry L. Wood | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 25 | Section 08, Daniel Puckett | DEF 14A | 2026-04-22 | 0001588978-26-000017 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 26 | Section 02, Barry L. Templin 2026-06-08 | Form 4 | 2026-06-10 | 0001628280-26-042213 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 27 | Section 02, Alaleh Nouri 2026-06-08 | Form 4 | 2026-06-10 | 0001628280-26-042223 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 28 | Section 02, Kevin Waters 2026-06-08 | Form 4 | 2026-06-10 | 0001628280-26-042218 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 29 | Section 02, Daniel Puckett 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042252 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 30 | Section 02, Frederic H. Moll 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042260 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 31 | Section 02, Antal Desai 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042277 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 32 | Section 02, Mary Garrett 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042270 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 33 | Section 02, Daniel Puckett 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042252 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 34 | Section 02, Thomas M. Prescott 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042256 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 35 | Section 02, Thomas M. Prescott 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042256 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 36 | Section 02, Frederic H. Moll 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042260 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 37 | Section 02, Elisabeth Little 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042263 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 38 | Section 02, Elisabeth Little 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042263 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 39 | Section 02, Taylor Harris 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042267 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 40 | Section 02, Taylor Harris 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042267 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 41 | Section 02, Mary Garrett 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042270 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 42 | Section 02, Amy Dodrill 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042273 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 43 | Section 02, Amy Dodrill 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042273 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 44 | Section 02, Antal Desai 2026-06-09 | Form 4 | 2026-06-10 | 0001628280-26-042277 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 45 | Section 02, Larry L. Wood 2026-08-07 | Form 4 | 2026-08-10 | 0001628280-26-054970 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 46 | Section 02, Barry L. Templin 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057163 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 47 | Section 02, Alaleh Nouri 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057165 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 48 | Section 02, Alaleh Nouri 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057165 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 49 | Section 02, Pooja Sharma 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057156 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 50 | Section 02, Pooja Sharma 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057156 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 51 | Section 02, Kevin Waters 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057160 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 52 | Section 02, Kevin Waters 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057160 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 53 | Section 02, Barry L. Templin 2026-08-13 | Form 4 | 2026-08-14 | 0001628280-26-057163 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 54 | Section 02, Barry L. Templin 2026-09-09 | Form 4 | 2026-09-10 | 0001588978-26-000032 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 55 | Section 02, Kevin Waters 2026-09-09 | Form 4 | 2026-09-10 | 0001653771-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 56 | Section 02, Alaleh Nouri 2026-09-09 | Form 4 | 2026-09-10 | 0001599418-26-000002 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 57 | Section 02, Michael Mack 2026-10-02 | Form 4 | 2026-10-05 | 0001628280-26-064925 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 58 | Section 02, Michael Mack 2026-10-02 | Form 4 | 2026-10-05 | 0001628280-26-064925 | Insider equity transaction reported since the proxy statement. Filing ↗ |
| 59 | Section 06, 2026 vote | Form 8-K | 2026-06-10 | 0001588978-26-000026 | Item 5.07 · say-on-pay result. As reported: 73.11% (votes for as printed: 26,984,867). Filing ↗ |
| 60 | Section 06, 2025 vote | Form 8-K | 2025-06-11 | 0001588978-25-000038 | Item 5.07 · say-on-pay result. As reported: 95.48% (votes for as printed: 40,260,405). Filing ↗ |
| 61 | Section 06, 2024 vote | Form 8-K | 2024-06-05 | 0001628280-24-026712 | Item 5.07 · say-on-pay result. As reported: 96.76% (votes for as printed: 37,459,317). Filing ↗ |
| 62 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 63 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 64 | Section 09b board cost (computed) | Computed | — | — | Cash 471,640 + equity 691,502 + all other 0 = 1,163,142, summed across the director compensation table rows.machine: formula: Σ = 1,163,142 |
| 65 | PROCEPT BioRobotics (subject), Section 10b CEO total | DEF 14A | 2026-04-22 | 0001588978-26-000017 | CEO total compensation as printed in PROCEPT BioRobotics's own proxy. As printed: 16,783,853. Filing ↗machine: r2 · c48 · span 520911–520921 |
| 66 | Silk Road Medical, Section 10b CEO total | DEF 14A | 2024-04-26 | 0001397702-24-000024 | CEO total compensation as printed in Silk Road Medical's own proxy. As printed: 13,423,834. Filing ↗machine: r2 · c8 · span 1756696–1756706 |
| 67 | Nevro, Section 10b CEO total | DEF 14A | 2024-04-12 | 0000950170-24-044100 | CEO total compensation as printed in Nevro's own proxy. As printed: 11,453,548. Filing ↗machine: r2 · c16 · span 631983–631993 |
| 68 | Revance Therapeutics, Section 10b CEO total | DEF 14A | 2024-03-21 | 0001479290-24-000071 | CEO total compensation as printed in Revance Therapeutics's own proxy. As printed: 10,068,915. Filing ↗machine: span 884809–884819 |
| 69 | Inspire Medical Systems, Section 10b CEO total | DEF 14A | 2026-03-20 | 0001140361-26-010490 | CEO total compensation as printed in Inspire Medical Systems's own proxy. As printed: 7,711,784. Filing ↗machine: r2 · c25 · span 1164868–1164877 |
| 70 | Certara, Section 10b CEO total | DEF 14A | 2026-04-03 | 0001104659-26-039372 | CEO total compensation as printed in Certara's own proxy. As printed: 6,491,387. Filing ↗machine: r1 · c42 · span 883232–883241 |
| 71 | RxSight, Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187240 | CEO total compensation as printed in RxSight's own proxy. As printed: 4,650,661. Filing ↗ |
| 72 | OrthoPediatrics, Section 10b CEO total | DEF 14A | 2026-04-20 | 0001425450-26-000027 | CEO total compensation as printed in OrthoPediatrics's own proxy. As printed: 3,331,481. Filing ↗machine: r2 · c36 · span 363407–363416 |
| 73 | Paragon 28, Section 10b CEO total | DEF 14A | 2024-04-05 | 0001193125-24-088613 | CEO total compensation as printed in Paragon 28's own proxy. As printed: 3,232,420. Filing ↗machine: t193 · r2 · c31 · span 598805–598814 |
| 74 | Penumbra, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001321732-26-000010 | CEO total compensation as printed in Penumbra's own proxy. As printed: 851,621. Filing ↗machine: span 424797–424804 |
| 75 | Section 10a, Nevro reciprocity | DEF 14A | — | 0000950170-24-044100 | Nevro's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 76 | Section 10a, Inspire Medical Systems reciprocity | DEF 14A | — | 0001140361-26-010490 | Inspire Medical Systems's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 77 | Section 10a, RxSight reciprocity | DEF 14A | — | 0001193125-26-187240 | RxSight names PROCEPT BioRobotics in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 78 | Section 10a, Silk Road Medical reciprocity | DEF 14A | — | 0001397702-24-000024 | Silk Road Medical's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 79 | Section 10a, Paragon 28 reciprocity | DEF 14A | — | 0001193125-24-088613 | Paragon 28's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 80 | Section 10a, Penumbra reciprocity | DEF 14A | — | 0001321732-26-000010 | Penumbra's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 81 | Section 10a, Certara reciprocity | DEF 14A | — | 0001104659-26-039372 | Certara's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
| 82 | Section 10a, Revance Therapeutics reciprocity | DEF 14A | — | 0001479290-24-000071 | Revance Therapeutics's most recent proxy was read; its disclosed peer group does not include PROCEPT BioRobotics. Filing ↗ |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.